Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL6552 | 1.00 | — | — | |
| Iodide SCHEMBL28508872 | 1.00 | CA4 (0.33) | — | |
| Iodide SCHEMBL3276834 | 0.82 | — | — | |
| Iodide SCHEMBL2939538 | 0.82 | — | — | |
| Iodide SCHEMBL31341551 | 0.82 | — | — | |
| Iodide SCHEMBL3276831 | 0.82 | — | — | |
| Iodide SCHEMBL4005731 | 0.82 | — | — | |
| Iodide SCHEMBL2939541 | 0.82 | — | — | |
| Silver SCHEMBL22462422 | 0.82 | — | — | |
| Iodide SCHEMBL22616410 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119009159-A | Additive of water-based zinc ion battery, electrolyte and water-based zinc ion battery | 中国科学院深圳先进技术研究院 | 2024-11-22 | — | — | CN | disclosed |
| CN-116315161-A | Water-based electrolyte, preparation method and battery | 深圳理工大学(筹) | 2023-06-23 | — | — | CN | disclosed |
| WO-2018231782-A2 | METAL COMPLEXES AS PHARMACEUTICALS FOR TREATMENT AND PREVENTION OF CANCER AND INFLAMMATORY DISEASES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2018-12-20 | — | — | WO | disclosed |
| US-20180353539-A1 | METAL COMPLEXES AS PHARMACEUTICALS FOR TREATMENT AND PREVENTION OF CANCER AND INFLAMMATORY DISEASES | UNIV SOUTHERN CALIFORNIA (US) | 2018-12-13 | — | — | US | disclosed |
| CN-101193893-B | Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group | L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA'DI ESERCIZIO S.P.A. (IT) | 2011-12-14 | — | — | CN | disclosed |
| CN-101193893-A | Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group | MOLTENI & C (IT) | 2008-06-04 | — | — | CN | disclosed |